FINWIRES · TerminalLIVE
FINWIRES

Transat航空宣布2026-27冬季蒙特利尔航线新增阿鲁巴、巴巴多斯和卡波圣卢卡斯航线。

By

-- Transat A.T (TRZ.TO) 周一宣布，将在其 2026-2027 年冬季航班时刻表中新增三条从蒙特利尔出发的阳光度假目的地航线。 新航线包括阿鲁巴的奥兰杰斯塔德、巴巴多斯的布里奇顿以及墨西哥的圣何塞德尔卡沃。飞往圣何塞德尔卡沃的航班将于 12 月 10 日开通，每周一班；飞往奥兰杰斯塔德的航班将于 12 月 12 日开通，每周一班；而飞往布里奇顿的航班将于 12 月 13 日开通，每周两班。 “市场对阳光度假目的地的需求依然强劲，这三条从蒙特利尔出发的新航线使我们能够通过拓展航线网络来满足这一需求。通过新增阿鲁巴、巴巴多斯和洛斯卡沃斯航线，我们将继续执行以多元化和优化南部航线网络为核心的战略，从而更好地服务我们的客户。”首席营收官塞巴斯蒂安·庞塞 (Sebastian Ponce) 表示。 这些航班现已开放预订，但航班时刻表可能会根据审批情况和机场空位情况而有所调整。加拿大越洋航空补充道，将在未来几周内继续公布其完整的冬季航班计划的更多细节。 加拿大越洋航空的股票在多伦多证券交易所收盘上涨0.02美元，至2.63美元。

Price: $2.60, Change: $-0.01, Percent Change: -0.38%

Related Articles

Asia

Ora Banda Mining Appoints Chair-elect

Ora Banda Mining (ASX:OBM) has appointed John Richards as chair-elect, with plans for him to assume the role following the retirement of current Chair Peter Mansell at the company's annual general meeting in November, according to a Tuesday filing with the Australian bourse.Richards is currently non-executive chair of Sandfire Resources (ASX:SFR) and lead independent non-executive director of Sheffield Resources (ASX:SFX), the filing added.

$ASX:OBM$ASX:SFR$ASX:SFX
Research

Research Alert: Universal Health Services: Q1 Eps Tops Estimates

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:UHS delivered solid Q1 results, with adjusted EPS of $5.62 (up 16.1% Y/Y), $0.16 above consensus, while revenue grew 9.6% to $4.495B due to higher prices despite modest patient volumes. Same-facility acute care revenue increased 8.2% on flat adjusted admissions but 6.3% growth in revenue per admission, while behavioral health saw 1.2% admission growth and 7.3% revenue growth. We think the $835M Talkspace acquisition may expand UHS's virtual behavioral health capabilities and broaden payor mix. Management expects the deal to close in Q3. Operating cash flow improved 11.7% to $402M, and UHS repurchased $127.3M in stock, though adjusted EBITDA margin compressed 20 bps to 14.4% on higher operating expenses. We think behavioral health staffing challenges persist but expect the Talkspace integration to create growth opportunities.

$UHS
Research

Research Alert: Cls Q1: Blistering Fy 26 Guidance And Cpo Win Tempered By Capital Demands

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Q1 revenues of $4.05B (+53%) and adjusted EPS of $2.16 (+80%) both exceeded guidance on accelerating hyperscaler demand. Adjusted operating margin reached a record 8.0%, due to higher-value CCS offerings, which grew 76% to $3.24B, with segment margin expanding to 8.6%. The company secured a new CPO switch program with a hyperscaler customer expected to ramp in 2027, and we expect more color tomorrow. Management raised 2026 guidance to $19.0B revenue (from $17.0B) and $10.15 adjusted EPS (from $8.75), representing over $6.5B in revenue growth. Stronger growth is anticipated for 2027 based on improved customer visibility and new program wins. The company enlarged its balance sheet by upsizing its credit facility to $2.5B, with revolver capacity increased to $1.75B. FCF of $137.9M remained robust despite elevated capex of $218.4M to support capacity expansion. Share buybacks slowing, FCF guidance lagging, and a +50% month may be contributing to the after-hours selloff.

$CLS